Evaluate the Effect of Dietary Supplement Combined Supervised Exercise on Physical Performance and Body Composition Among Patients With Sarcopenia and Severe Sarcopenia Comorbid With COPD or ILD: A Prospective, Multi-center Cohort Study

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This trial is a prospective multi-center study. The purpose of this study is to evaluate the effect of dietary supplement combined with supervised exercised on the physical performance, body composition and lung function among patients with Sarcopenia and severe Sarcopenia in chronic lung disease. After participants enroll in this study, 12-week clinical trial will be conducted to analyze the improvement regarding Sarcopenia and different severity of Sarcopenia before and after the intervention of exercise and nutritional products, which can further provide reference for clinical intervention and rehabilitation.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from Department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.

• Outpatients who meet the diagnostic criteria for Sarcopenia after evaluation by a physician.

Locations
Other Locations
Taiwan
Taichung Veterans General Hospital
RECRUITING
Taichung
Contact Information
Primary
Pin-Kuei Fu, PhD
yetquen@vghtc.gov.tw
04-23592525
Time Frame
Start Date: 2023-03-01
Estimated Completion Date: 2032-10-31
Participants
Target number of participants: 100
Treatments
Experimental: nutritional supplements and supervised exercise on Sarcopenia group and Severe Sarcopenia group
The intervention consisted of providing nutritional supplements and supervised exercise for 12 weeks. After the intervention (the 12th week), the trial commissioned company provides nutritional supplements with a market price of about NT$4,000 per month for three months free to participants who are willing to continue taking the products. Those participants will be tracked for one year.
Sponsors
Leads: Orient Europharma Co., Ltd.

This content was sourced from clinicaltrials.gov